We serve Chemical Name:5-Bromo-6-chromanol CAS:32337-88-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Bromo-6-chromanol
CAS.NO:32337-88-5
Synonyms:5-BROMO-BENZOOXAZOLE-2-CARBOXYLIC ACID METHYL ESTER;Methyl 5-bromobenzo[d]oxazole-2-carboxylate;5-bromo-chroman-6-ol;5-bromo-benzoxazole-2-carboxylic acid methyl ester
Molecular Formula:C9H9BrO2
Molecular Weight:229.07100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.46000
Exact Mass:227.97900
LogP:2.47970
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-BROMO-BENZOOXAZOLE-2-CARBOXYLIC ACID METHYL ESTER chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-benzoxazole-2-carboxylic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-benzoxazole-2-carboxylic acid methyl ester Use and application,5-BROMO-BENZOOXAZOLE-2-CARBOXYLIC ACID METHYL ESTER technical grade,usp/ep/jp grade.
Related News: Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting. methyl (E)-2-(N-(3-(2-(4-isopropylthiazol-2-yl)vinyl)benzyl)-N-(3-(phenylsulfonamido)propyl)sulfamoyl)benzoate manufacturers Cholesterol drug Crestor, blood thinner Brilinta and acid reflux med Nexium have all suffered as a result. Brilinta, for example, saw emerging markets sales drop 40% at constant currencies to $180 million in the first six months of 2021. 5-amino-6-chloro-N-{[1-(3,3-dimethyl-2-oxobutyl)piperidin-4-yl]methyl}-2-methylimidazo[1,2-a]pyridine-8-carboxamide suppliers MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. 1-(3-chloropropyl)-1-nitroso-3-(2-(trihexylgermyl)ethyl)urea vendor & factory.
